Eravacycline dihydrochloride - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for eravacycline dihydrochloride and what is the scope of patent protection?
Eravacycline dihydrochloride
is the generic ingredient in one branded drug marketed by Tetraphase Pharms and is included in one NDA. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.Eravacycline dihydrochloride has seventy-eight patent family members in thirty-two countries.
Summary for eravacycline dihydrochloride
International Patents: | 78 |
US Patents: | 3 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 18 |
Clinical Trials: | 10 |
Patent Applications: | 3 |
DailyMed Link: | eravacycline dihydrochloride at DailyMed |
Recent Clinical Trials for eravacycline dihydrochloride
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Tetraphase Pharmaceuticals, Inc. | Phase 3 |
Tetraphase Pharmaceuticals, Inc. | Phase 1 |
Department of Health and Human Services | Phase 1 |
US Patents and Regulatory Information for eravacycline dihydrochloride
International Patents for eravacycline dihydrochloride
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Denmark | 2682387 | See Plans and Pricing | |
China | 102177134 | C7-fluoro substituted tetracycline compounds | See Plans and Pricing |
Denmark | 2323972 | See Plans and Pricing | |
South Korea | 20190065414 | 에라바사이클린의 결정질 형태 | See Plans and Pricing |
Norway | 2019010 | See Plans and Pricing | |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for eravacycline dihydrochloride
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
2323972 | LUC00107 | Luxembourg | See Plans and Pricing | PRODUCT NAME: ERAVACYCLINE OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUI-CI; AUTHORISATION NUMBER AND DATE: EU/1/18/1312 20180924 |
2323972 | 1990014-1 | Sweden | See Plans and Pricing | PRODUCT NAME: ERAVACYCLINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF; REG. NO/DATE: EU/1/18/1312 20180924 |
2323972 | 2019C/511 | Belgium | See Plans and Pricing | PRODUCT NAME: ERAVACYCLINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; AUTHORISATION NUMBER AND DATE: EU/1/18/1312 20180924 |
2323972 | 19C1012 | France | See Plans and Pricing | PRODUCT NAME: ERAVACYCLINE OU L'UN DE SES SELS PHARMACEUTIQUEMENT ACCEPTABLES; REGISTRATION NO/DATE:EU/1/18/1312 20180924 |
2323972 | PA2019009,C2323972 | Lithuania | See Plans and Pricing | PRODUCT NAME: ERAVACIKLINAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA; REGISTRATION NO/DATE: EU/1/18/1312 C(2018)6231 20180920 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |